Clin2
NCT07599410Possibly a fitRecruiting

Testing HRS9531 for Type 2 Diabetes Blood Sugar Control

T2DM

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests whether a new tablet called HRS9531 helps people with type 2 diabetes control their blood sugar better. You would take it along with your current diabetes management (lifestyle changes or metformin) over several months.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
240 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • Age 18–70 and diagnosed with type 2 diabetes for at least 6 months
  • Blood sugar control level (HbA1c) between 7.5% and 10.5%
  • Currently managing diabetes with lifestyle changes alone for 8+ weeks, or taking only metformin (stable dose) for 8+ weeks
  • Fasting blood glucose not higher than 15 mmol/L and BMI between 20–40 kg/m²
  • No recent severe low blood sugar episodes, heart attacks, strokes, or severe diabetes complications
  • Willing to use contraception and not plan pregnancy for 2 months after the study ends

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07527650Recruiting· Phase 2
Testing HM15275 for Type 2 Diabetes Management

This study tests a new medication called HM15275 to help control blood sugar in people with type 2 diabetes. The trial will check if the medication works well and is safe when added to diet, exercise, or metformin treatment.

Mesa, Arizona
NCT07060456Recruiting· Phase 3
New drug for type 2 diabetes with insulin

This trial tests a new medicine called HRS9531 for people with type 2 diabetes who already use basal insulin. It aims to see if adding this drug helps control blood sugar better.

Beijing, Beijing Municipality
NCT07193459Recruiting· Phase 3
Study of an oral tablet for type 2 diabetes

This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.

Beijing, Beijing Municipality
NCT07872436Not yet recruiting· Phase 2
VCT220 tablets for type 2 diabetes with poor blood sugar control

This trial tests an oral medication called VCT220, which may help lower blood sugar in adults with type 2 diabetes who aren't well controlled with current treatments. It aims to see if it's safe and effective compared to standard care.

Beijing, Beijing Municipality
NCT07755150Not yet recruiting· Phase 2
Study of an experimental pill for type 2 diabetes

This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.

Beijing
NCT07156500Not yet recruiting· Phase 3
Investigational drug study for type 2 diabetes not controlled by diet and exercise

This study tests an investigational drug called HS-20094 to see how well it controls blood sugar in people with type 2 diabetes. It may help you manage your diabetes better if diet and exercise alone are not enough.

Beijing, Beijing Municipality

Hear when a new T2DM trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.